Fund moves

Danaher Corporation (DHR): Lord, Abbett & Co. LLC reduced its stake -768K shares

Lord, Abbett & Co. LLC reduced its stake in Danaher Corporation, per its Q3 2024 13F.

939K
Shares reported · -768K vs prior quarter
0.83%
Disclosed portfolio weight
$261M
Reported value
Holdings as of
Sep 30, 2024
Filed
Dec 13, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 25, 2024InsiderOfficer sold ~$1.99M of DHR shares in the open market
  2. Nov 26, 2024InsiderOfficer sold ~$6.23M of DHR shares in the open market

What came next

  1. Jan 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  2. Jan 30, 2025InsiderOfficer sold ~$1.28M of DHR shares in the open market
  3. Feb 3, 2025FDARecall: Access Erythropoietin (EPO), Catalog Number - A16364 a glycoprotein (~30,400 Daltons) produced primarily by the kidney, is the principal factor regulating red…
  4. Feb 5, 2025FDARecall: Access 2 Immunoassay Analyzer, Catalog Number 81600N
  5. Feb 5, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137.
  6. Feb 6, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137, with Component PCB, TSI/RSI firmware C29278
  7. Feb 7, 2025InsiderDirector sold ~$114K of DHR shares in the open market
  8. Feb 13, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  9. Feb 21, 2025FDAFDA device clearance: Xpert® FII & FV
  10. Feb 25, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  11. Feb 26, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065 The Beckman Coulter DxC 500 AU Clinical Chem…
  12. Feb 26, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  13. Feb 27, 2025FDARecall: Access Vitamin B12 Reagent, Catalog Number 33000, Lot Number 439850
  14. Mar 5, 2025FDAFDA device clearance: Access Cortisol; DxC 500i Clinical Analyzer
  15. Mar 17, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065 Software versions: V1.3, V1.4, V1.4.1, V1.4.…
  16. Mar 20, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065. The Beckman Coulter DxC 500 AU Clinical Che…
  17. Mar 21, 2025FDARecall: Radiometer ABL90 Series - Radiometer ABL90 FLEX Model Number 393-090 Radiometer ABL90 Series - Radiometer ABL90 FLEX PLUS Model Number 393-092 The Radiometer A…
  18. Mar 27, 2025FDARecall: Beckman Coulter DxI 9000 Access Immunoassay Analyzer
  19. Mar 27, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  20. Mar 28, 2025FDAFDA device clearance: Access Toxo IgG
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

How this filing works

Explore the data

Common questions

What does this filing report about Danaher Corporation (DHR) stock?

Lord, Abbett & Co. LLC reduced its stake in Danaher Corporation, per its Q3 2024 13F. Now 939K shares, $261M reported value, 0.83% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Sep 30, 2024. Filed: Dec 13, 2024.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Danaher Corporation recently?

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days. They are listed on the DHR page.

Does this mean DHR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data